Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study
- 1Endocrinology and Metabolic Medicine, Imperial College London, St Mary's Hospital, London, UK. robert.elkeles@imperial.nhs.uk
- 0Endocrinology and Metabolic Medicine, Imperial College London, St Mary's Hospital, London, UK. robert.elkeles@imperial.nhs.uk
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Coronary artery calcification score (CACS) strongly predicts cardiovascular events in type 2 diabetes (T2DM) patients. Adding CACS to existing risk models significantly improves cardiovascular event prediction.
Area Of Science
- Cardiology
- Endocrinology
- Preventive Medicine
Background
- Type 2 diabetes (T2DM) significantly increases cardiovascular disease (CVD) risk.
- Accurate risk stratification is crucial for preventing CVD events in T2DM patients.
- Established risk models may not fully capture individual CVD risk in T2DM.
Purpose Of The Study
- To evaluate the predictive value of coronary artery calcification score (CACS) for cardiovascular events in asymptomatic T2DM patients.
- To determine if CACS improves risk prediction beyond traditional risk factors and models.
Main Methods
- Prospective cohort study (PREDICT Study) of 589 T2DM patients without prior CVD.
- Measured CACS and various risk factors (lipids, HOMA-IR, urine albumin-creatinine ratio).
- Followed participants for a median of 4 years to identify first coronary heart disease and stroke events.
Main Results
- CACS was a significant independent predictor of cardiovascular events (P < 0.001).
- Higher CACS levels were associated with substantially increased event risk (e.g., CACS >1000 AU showed 19.8-fold risk).
- CACS improved the area under the ROC curve from 0.63 to 0.73 compared to the UKPDS risk engine alone (P = 0.03).
Conclusions
- Coronary artery calcification scoring is a powerful tool for predicting cardiovascular events in asymptomatic T2DM individuals.
- CACS enhances the predictive capability of established cardiovascular risk assessment models in this population.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.